Thierry Peyrard, PharmD, PhD, European Specialist in Laboratory Medicine, has 30 years of experience in the field of transfusion medicine and blood banking. Until 2024, he served as Director of the National Reference Department of Immunohaematology and Rare Blood, at the French Blood Establishment (EFS) in Paris, France. He is currently the Responsible Person of the French Blood Establishment, in charge at a national level for the quality and safety of blood products, and National Director of Medical Affairs and Research. He is a research director in a state-run scientific institution (UMR_S1134 BIGR), involving the French National Institute of Health and Medical Research, University of Paris City & University of Antilles, and EFS, in a team whose main focus are the characterisation of new blood group systems/antigens and immunological safety of blood transfusion in patients with sickle cell disease. He authored/co-authored 100 peer-reviewed publications, and actively contributed to the discovery of 10 blood group systems and 15 red cell antigens. He is a member of the French National Academy of Pharmacy, representing the fields of immunohaematology and blood transfusion. He is the Vice-Chair of the ISBT Working Party on Rare Donors, and Past-Chair of the ISBT Working Party on Immunohaematology. Thierry Peyrard is Associate Editor of Transfusion, the official Journal of the AABB, and the 2025 AABB Sally Frank Award recipient.

Emma is a Transfusion Medicine Specialist with Australian Red Cross Lifeblood, based in Brisbane and working as National Molecular Lead. A dual-trained haematologist, she worked in Canberra for seven years and Darwin for three before completing further qualifications in molecular haematology. Her interests focus on red cell genetics - diagnostic methods and clinical application.

Patrick is a Clinical Scientist in Donor and Patient Testing at the New Zealand Blood Service. His career spans more than two decades across transfusion medicine, infectious diseases, molecular diagnostics and public health, and he has held scientific and research roles at the U.S. Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA) and the UK Health Security Agency. His broad interests in transfusion medicine are reflected in a diverse range of initiatives he has led, spanning blood components development, immunohaematology, transfusion transmitted infectious diseases and blood supply strategy.

Sarah Kowalski is a Senior Transfusion Scientist at Australian Red Cross Lifeblood and a Course Coordinator and Lecturer at the University of Adelaide. With over 16 years' experience in transfusion medicine, she develops educational programs for healthcare professionals and teaches Transfusion and Haemostasis within the Laboratory Medicine program.